Perspective article - continued
Sort by: Newest first Oldest first A-Z Z-A
-
Prevention of medication-related osteonecrosis of the jaw Subscription
Severe bone damage in the jaw occurs in some people as an adverse reaction to certain medicines commonly used in the treatment of cancer and osteoporosis. There are a range of settings where pharmacists can contribute to the prevention of this painful and difficult-to-treat condition.
-
Pharmacokinetic considerations and challenges in oral anticancer drug therapy Subscription
A review of the pros and cons of oral anticancer drug therapy, as well as the pharmacokinetic barriers and potential solutions to oral chemotherapy in the home.
-
Substandard and falsified medicines: global and local efforts to address a growing problem Subscription
Substandard and falsified medicines pose a risk to public health all around the world.
-
Antidepressants in the treatment of major depression: a changing landscape for clinical decision making Subscription
With publication of the update to the National Institute of Health and Care Excellence depression guideline postponed until late 2019, this article aims to examine the findings of the Cipriani et al. meta-analysis in the wider context of the management of depression in the UK.
-
What could UK pharmacy teams learn about suicide prevention from North America? Subscription
From the perspective of their clinical and holistic role, and restriction of access to means, there are opportunities to involve pharmacy teams in suicide prevention. This article examines the published evidence-base and the success of ongoing programmes and initiatives in the United States and Canada to produce a set of recommendations for the benefit of UK practice on the opportunities community pharmacy teams have to raise awareness and help prevent suicide and self-harm.
-
Impact of an integrated pharmacy service on hospital admission costs Subscription
Northumberland was chosen as one of the national vanguard sites in early 2015, in response to the Five year forward view initiative. This article describes the evolution of the integrated pharmacy service, which now operates across organisational boundaries and in collaboration with other healthcare professionals, as well as the improvements in patient care, harm reduction and increased efficiencies achieved using a sustainable model of care.
-
The implications of the Montgomery judgment on pharmacy practice and patients with learning disability Subscription
The judgment in Montgomery v Lanarkshire (Scotland) 2015 introduced a new definition of informed consent which has implications for all healthcare professionals. This article focuses specifically on the implications for pharmacy practice and patients with learning disability. During consultations, both pharmacist prescribers and non-prescribing pharmacists must adhere to the provisions of the judgment to ensure patients provide informed consent. Particular issues arise where patients ...
-
Demonstrating the patient benefit and value for the NHS of community pharmacy: insight from the Community Pharmacy Future model Subscription
In the face of funding and efficiency cuts to community pharmacy, the role of the sector is coming under increasing pressure. The importance of outcomes evidence (particularly health economic evidence) is being brought sharply into focus. The profession must come together to produce the evidence needed to justify the services provided by community pharmacy and to support its future development. This article uses the Community Pharmacy Future (CPF) project, and the services developed ...
-
A new way to look at acute cough in the pharmacy Subscription
Cough is the most common symptom for which people seek medical advice, and patients with cough frequently present to community pharmacy. Cough can be either acute or chronic. Acute cough, defined as being of less than three weeks’ duration, is often caused by viral respiratory tract infection and is probably one of the most common reasons for accessing healthcare in the community. For these infections, no antiviral treatment exists and antibiotics have been shown to be ineffective in ...
-
The impact of the human papillomavirus vaccine in Scotland: a changing landscape Subscription
In the UK, cervical cancer is the second most common cancer in women aged under 35 years. Human papillomavirus (HPV) types 16 and 18 (both high risk) are necessary precipitants in at least 70% of cervical cancers but may contribute to more than 80% of cervical cancers in Scotland. Both the prophylactic bivalent (Cervarix; GlaxoSmithKline) and quadrivalent (Gardasil; Merck) vaccines prevent infection with HPV types 16 and 18, and have been shown to induce avid and sustained neutralising ...
Show 10 per page20 per page50 per page
